Yakishi Technology: Independent Director Candidate Statements and Commitments (Jinli)
Pharmaceutical Stone Technology: Announcement of Resolutions of the 22nd Meeting of the 3rd Board of Supervisors
Yakshi Technology: Independent Director Candidate Statements and Pledges (Jiang Xihe)
Yakushi Technology: Announcement on Remuneration Plans for Members of the 4th Board of Directors and Supervisory Board
Pharmaceutical Stone Technology: Nanjing Yakushi Technology Co., Ltd. Fund Raising Management System (revised in November 2024)
Yakishi Technology: Independent Director Nominee Statement and Commitment (Jinli)
Yakushi Technology: Announcement on the election of the Board of Supervisors for a new term
Yakushi Technology: Announcement on the election of the board of directors for a new term
Pharmaceutical Stone Technology: Nanjing Yakushi Technology Co., Ltd. Profit Distribution Management System (revised in November 2024)
Pharmaceutical Stone Technology: Nanjing Yakushi Technology Co., Ltd. External Guarantee Management System (revised in November 2024)
Pharmaceutical Stone Technology: Announcement of Resolutions of the 38th Meeting of the Third Board of Directors
Yakshi Technology: Independent Director Nominee\'s Statement and Commitment (Jiang Xihe)
Yakishi Technology: Notice on Convening the Company\'s Second Extraordinary General Meeting of Shareholders in 2024
Yakshi Technology: Independent Director Candidate Statement and Commitment (Zheng Xiaonan)
Yakshi Technology: Independent Director Nominee\'s Statement and Commitment (Zheng Xiaonan)
Yakushi Technology: Announcement on the Election of Staff Representative Supervisors for the 4th Board of Supervisors
Yakishi Technology: 300725 Yakishi Technology Investor Relations Management Information 20241031
Yakushi Technology: Management System for Directors, Supervisors, and Senior Management to Hold and Trade the Company\'s Shares (October 2024)
Yakshi Technology: Report for the third quarter of 2024
Yakushi Technology: Announcement on the absorption and merger of wholly-owned subsidiaries
No Data
No Data